DOSSIER · 13F Holders · Q2 2026
CYTOMED THERAPEUTICS LIMITED
4 institutions still hold CYTOMED THERAPEUTICS LIMITED as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP Y1R80M106·4 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
4 institutions reported CYTOMED THERAPEUTICS LIMITED in Q2 2026. Axiom Investment Management LLC leads at 59.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.